Back
Beam Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
73
BEAM
Beam Therapeutics
Last Price:
$19.19
Seasonality Move:
-9.19%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing selling pressure, which indicates risk of future bearish movement.
Beam Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.04 | Buy |
20-day SMA: | 17.62 | Buy |
50-day SMA: | 17.74 | Buy |
200-day SMA: | 23.04 | Sell |
8-day EMA: | 18.43 | Buy |
20-day EMA: | 17.8 | Buy |
50-day EMA: | 18.15 | Buy |
200-day EMA: | 22.01 | Sell |
Beam Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.36 | Buy |
Relative Strength Index (14 RSI): | 60.61 | Buy |
Chaikin Money Flow: | -1952859 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.39 - 18.45) | Buy |
Bollinger Bands (100): | (15.74 - 25.38) | Sell |
Beam Therapeutics Technical Analysis
Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Beam Therapeutics Stock
Is Beam Therapeutics Stock a Buy?
-
Beam Therapeutics share price is 19.18 while BEAM 8-day simple moving average is 18.04, which is a Buy signal.
-
The stock price of BEAM is 19.18 while Beam Therapeutics 20-day SMA is 17.62, which makes it a Buy.
-
Beam Therapeutics 50-day simple moving average is 17.74 while BEAM share price is 19.18, making it a Buy technically.
-
BEAM stock price is 19.18 and Beam Therapeutics 200-day simple moving average is 23.04, creating a Sell signal.
BEAM Technical Analysis vs Fundamental Analysis
Buy
73
Beam Therapeutics (BEAM)
is a Buy
Is Beam Therapeutics a Buy or a Sell?
-
Beam Therapeutics stock is rated a BuyThe current Beam Therapeutics [BEAM] share price is $19.18. The Score for BEAM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Beam Therapeutics Stock Info
Market Cap:
1.9B
Price in USD:
19.18
Share Volume:
2.8M
Beam Therapeutics 52-Week Range
52-Week High:
35.25
52-Week Low:
13.53
Buy
73
Beam Therapeutics (BEAM)
is a Buy
Beam Therapeutics Share Price Forecast
-
What is the Beam Therapeutics stock price today?The Beam Therapeutics stock price is 19.18 USD today.
-
Will BEAM stock go up or go down?Beam Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Beam Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics is not overvalued.
Is Beam Therapeutics Stock a Buy?
-
Beam Therapeutics share price is 19.18 while BEAM 8-day exponential moving average is 18.43, which is a Buy signal.
-
The stock price of BEAM is 19.18 while Beam Therapeutics 20-day EMA is 17.80, which makes it a Buy.
-
Beam Therapeutics 50-day exponential moving average is 18.15 while BEAM share price is 19.18, making it a Buy technically.
-
BEAM stock price is 19.18 and Beam Therapeutics 200-day simple moving average is 22.01, creating a Sell signal.
Fundamental Analysis of Beam Therapeutics
Is Beam Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.18 per share, and an increase next year of $0.02 per share.
Technical Analysis of Beam Therapeutics
Should I short Beam Therapeutics stock?
-
BEAM Moving Average Covergence Divergence (MACD) indicator is 0.36, suggesting Beam Therapeutics is a Buy
-
Beam Therapeutics Relative Strength Index (RSI) is 60.61, which suggest Beam Therapeutics is overbought
-
The Bollinger Bands (25) for Beam Therapeutics is (16.39 - 18.45), which suggest Beam Therapeutics is a Sell
-
The Bollinger Bands (100) for Beam Therapeutics is (15.74 - 25.38), which suggest Beam Therapeutics is a Sell
* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.